Alivus Life Sciences Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 662.82 | 711.90 | 686.82 |
| Operating Expense | 428.70 | 474.59 | 467.27 |
| Net Profit | 160.08 | 162.66 | 150.26 |
| Net Profit Margin | 24.15% | 22.85% | 21.88% |
| Earning Per Share | 13.04 | 13.23 | 12.25 |
| EBIDTA | 232.25 | 235.26 | 225.33 |
| Effective Tax Rate | 21.47% | 21.53% | 24.56% |
Particulars
Jun 2026
Revenue662.82
Operating Expense428.70
Net Profit160.08
Net Profit Margin24.15
Earning Per Share13.04
EBIDTA232.25
Effective Tax Rate21.47
